{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:11:32Z","timestamp":1758845492413},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res. Exp. Med."],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1007\/s004330050123","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T09:25:39Z","timestamp":1030267539000},"page":"253-262","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus"],"prefix":"10.1007","volume":"199","author":[{"given":"Ravi","family":"Walli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerlinde M.","family":"Michl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"M\u00fchlbayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank D.","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,25]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1464-5491.1988.tb00996.x","volume":"5","author":"CJ Bailey","year":"1988","unstructured":"Bailey CJ (1988) Metformin revisited: its actions and indications for use. Diabet Med 5: 315\u2013320","journal-title":"Diabet Med"},{"key":"1_CR2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0149-2918(98)80086-6","volume":"20","author":"ZT Bloomgarden","year":"1998","unstructured":"Bloomgarden ZT (1998) Insulin resistance: current concepts. Clin Ther 20: 216\u2013231","journal-title":"Clin Ther"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","volume":"354","author":"K Brinkman","year":"1999","unstructured":"Brinkman K, Smeitink JA, Romijn JA, et al (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354: 1112\u20131115","journal-title":"Lancet"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, et al (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51\u201358","journal-title":"AIDS"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2362.1994.tb02373.x","volume":"24","author":"P Cremer","year":"1994","unstructured":"Cremer P, Nagel D, Labrot B, et al (1994) Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective G\u00f6ttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 24: 444\u2013453","journal-title":"Eur J Clin Invest"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2265.1994.tb03012.x","volume":"40","author":"SV Gelding","year":"1994","unstructured":"Gelding SV, Robinson S, Lowe S, Niththyananthan R, Johnston DG (1994) Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity. Clin Endocrinol (Oxf) 40: 611\u2013615","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1_CR7","first-page":"433","volume":"46","author":"MN Ghazzi","year":"1997","unstructured":"Ghazzi MN, Perez JE, Antonucci TK, et al (1997) Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes 46: 433\u2013439","journal-title":"The Troglitazone Study Group. Diabetes"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)37569-6","volume":"37","author":"IJ Goldberg","year":"1996","unstructured":"Goldberg IJ (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37: 693\u2013707","journal-title":"J Lipid Res"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00007611-199901000-00002","volume":"92","author":"MC Granberry","year":"1999","unstructured":"Granberry MC, Fonseca VA (1999) Insulin resistance syndrome: options for treatment. South Med J 92: 2\u201315","journal-title":"South Med J"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/j.1875-9114.1998.tb03928.x","volume":"18","author":"MC Granberry","year":"1998","unstructured":"Granberry MC, Schneider EF, Fonseca VA (1998) The role of troglitazone in treating the insulin resistance syndrome. Pharmacotherapy 18: 973\u2013987","journal-title":"Pharmacotherapy"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","volume":"338","author":"SE Inzucchi","year":"1998","unstructured":"Inzucchi SE, Maggs DG, Spollett GR, et al (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus [see comments]. N Engl J Med 338: 867\u2013872","journal-title":"N Engl J Med"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0753-3322(91)90067-4","volume":"45","author":"M Janssen","year":"1991","unstructured":"Janssen M, Rillaerts E, De Leeuw I (1991) Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM). Biomed Pharmacother 45: 363\u2013367","journal-title":"Biomed Pharmacother"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/BF00418542","volume":"39","author":"S Kumar","year":"1996","unstructured":"Kumar S, Boulton AJ, Beck Nielsen H, et al (1996) Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia 39: 701\u2013709","journal-title":"Troglitazone Study Group. Diabetologia"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0006-2952(97)00229-3","volume":"54","author":"JM Lenhard","year":"1997","unstructured":"Lenhard JM, Kliewer SA, Paulik MA, Plunket KD, Lehmann JM, Weiel JE (1997) Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways. Biochem Pharmacol 54: 801\u2013808","journal-title":"Biochem Pharmacol"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00042560-199811010-00015","volume":"19","author":"JC Lo","year":"1998","unstructured":"Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M (1998) Body shape changes in HIV-infected patients [letter]. J Acquir Immune Defic Syndr Hum Retrovirol 19: 307\u2013308","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"1_CR16","unstructured":"Saint-Marc T, Touraine JL (1998) Truncal adiposity sydrome hyperinsulinemia, endocrine and metabolic disorders in patients receiving HIV protease inhibitors (abstract). AIDS: S54"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00002030-199905280-00023","volume":"13","author":"T Saint-Marc","year":"1999","unstructured":"Saint-Marc T, Touraine JL (1999) Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy. AIDS 13: 1000\u20131002","journal-title":"AIDS"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM199803263381302","volume":"338","author":"S Schwartz","year":"1998","unstructured":"Schwartz S, Raskin P, Fonseca V, Graveline JF (1998) Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group [see comments]. N Engl J Med 338: 861\u2013866","journal-title":"N Engl J Med"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/ajcn\/54.1.26","volume":"54","author":"KR Segal","year":"1991","unstructured":"Segal KR, Burastero S, Chun A, Coronel P, Pierson RN Jr, Wang J (1991) Estimation of extracellular and total body water by multiple-frequency bioelectrical-impedance measurement [see comments]. Am J Clin Nutr 54: 26\u201329","journal-title":"Am J Clin Nutr"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02560501","volume":"27","author":"S Segerer","year":"1999","unstructured":"Segerer S, Bogner JR, Walli R, Loch O, Goebel FD (1999) Hyperlipidemia under therapy with protease inhibitors. Infection 27: 77\u201381","journal-title":"Infection"},{"key":"1_CR21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/0956462981921189","volume":"9","author":"AJ Shaw","year":"1998","unstructured":"Shaw AJ, McLean KA, Evans BA (1998) Disorders of fat distribution in HIV infection. Int J STD AIDS 9: 595\u2013599","journal-title":"Int J STD AIDS"},{"key":"1_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","volume":"47","author":"BM Spiegelman","year":"1998","unstructured":"Spiegelman BM (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507\u2013514","journal-title":"Diabetes"},{"key":"1_CR23","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","volume":"12","author":"R Viraben","year":"1998","unstructured":"Viraben R, Aquilina C (1998) Indinavir-associated lipodystrophy. AIDS 12: F37\u201339","journal-title":"AIDS"},{"key":"1_CR24","doi-asserted-by":"crossref","unstructured":"Walli R, Herfort O, Michl GM, et al (1998) Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. AIDS 12","DOI":"10.1097\/00002030-199815000-00001"}],"container-title":["Research in Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s004330050123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s004330050123\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s004330050123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T07:05:52Z","timestamp":1703919952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s004330050123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s004330050123","relation":{},"ISSN":["0300-9130","1433-8580"],"issn-type":[{"value":"0300-9130","type":"print"},{"value":"1433-8580","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}